Disparities in Clinical Research and Cancer Treatment

Disparities in Cancer | Clinical Oncology News - OncLive

This page features news articles, interviews in written and video format, and podcasts that focus on studies evaluating these various disparities and how they ...

Increasing Diversity in Clinical Trials to Reduce Health Disparities

If laboratory activities or a clinical trial for a new potential treatment for breast cancer do not study or include an adequate number of ...

Understanding Breast Cancer Racial Disparities

Research breakthroughs can only reach patients ... clinical trials, but most participants in breast cancer clinical trials are white.

The current status of clinical trials on cancer and age disparities ...

While two-thirds of cancer patients are over 65 years old, only about 25% of cancer trial participants reach that age [17]. Ethan et al.

Alliance Disparities Committee Corner

Under-enrollment of racial and ethnic minorities reduces the generalizability of research findings and represents a disparity in access to high-quality cancer ...

Understanding Disparities in Clinical Trial Enrollment

Overall, enrollment in clinical trials is minuscule, with less than 5 percent of all cancer patients currently enrolled in a clinical trial.

Disparities in Clinical Trial Enrollment Among NSCLC Patients

Patients treated outside of academic or research programs were less likely to enroll in trials. This included patients treated in community ...

Addressing Cancer Disparities Promotes Precision Medicine for All

Siteman Cancer Center pursues racial equity in clinical trials so that medical breakthroughs cure cancer for all members of our community.

The truths behind disparities in clinical trials

In terms of institutional barriers, clinical trials are often inaccessible to low-income patients of color because the trials are not being ...

Minority Health Month: Why Diversity is Necessary in Clinical Trials

Other barriers include lack of access to academic or specialty health care centers that offer trials, time to participate, and financial ...

The importance of diversity in clinical trials - AccessHope

A troubling gap exists between cancer treatment and cancer outcomes based on race, ethnicity, socioeconomic status, sexual orientation, ...

LBA66_PR Disparities in access to oncology clinical trials in Europe ...

To ascertain the extent of potential inequalities in access to clinical trials in Europe, we compared their distribution among European countries.

Addressing Demographic Disparities in Clinical Trials

Disparities in health care are not just limited to the delivery of care. They also exist in the way that clinical trials are structured.

Importance of participating in clinical trials, addressing racial ...

With the support of the V Foundation for Cancer Research, UNC Lineberger talked to former and current patients about their involvement in ...

Addressing Racial Disparities in Clinical Trials in Cholangiocarcinoma

From 2009 to 2022, yearly trends for the absolute number of clinical trial enrollees showed a decrease in the distribution of blacks from 16% to ...

Insights and Innovative Approaches to Addressing Disparities in ...

Cancer care disparities exist for underrepresented groups due to limited access to healthcare, clinical trials, and cultural barriers, ...

Cross-Sectional Analysis of Baseline Data From the mychoice Study

Racial disparities in cancer survival among randomized clinical trials patients of the southwest oncology group. J Natl Cancer Inst. Jul 15 ...

Health Disparities Research - MD Anderson Cancer Center

The MD Anderson Health Disparities Research department aims to eliminate disparities in cancer incidence, morbidity and mortality. Learn more.

Studies Offer Mix of Hope and Challenges in Addressing Cancer ...

... clinical trials and effective treatments for patients ... Studies Offer Mix of Hope and Challenges in Addressing Cancer Care Disparities.

Higher cancer rates in minoritized communities driven by disparities

Cancer disparities are most stark in Black and Indigenous populations, which have the highest overall cancer death rates of all US racial or ethnic groups.